Problem Statement
There is a lack of diverse principal investigators leading medical device clinical studies, which impedes the inclusion of representative patient populations from the communities they are trying to serve.
In today’s America, Black, Indigenous, (and) People Of Color (BIPOC) continue to have markedly worse health outcomes than White patients.
The differences are greatest for Black Americans. Compared to White patients, they are two to three times as likely to die of preventable heart disease and stroke. They also have higher rates of cancer, asthma, influenza, pneumonia, diabetes, HIV/AIDS, and homicide. For many of them, structural racism and unequal treatment remain a contributing factor to disease and death.